Do low testosterone levels contribute to the pathogenesis of asthma?

Medical Hypotheses

Volumn 76, Issue 4, 2011, Pages 585-588

  Canguven, Onder ^a   Albayrak, Selami ^a  

^a Kartal Training and Research Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANDROGEN; ANDROSTANOLONE; ANTIHISTAMINIC AGENT; ANTIINFLAMMATORY AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CILOMILAST; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYTOKINE; HISTIDINE DECARBOXYLASE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; LEUKOTRIENE; LONG ACTING DRUG; PHOSPHODIESTERASE; PHOSPHODIESTERASE IV INHIBITOR; PRASTERONE; PROGESTERONE; PROSTAGLANDIN SYNTHASE INHIBITOR; ROFLUMILAST; SHORT ACTING DRUG; TESTOSTERONE; THEOPHYLLINE;

ANTIBODY PRODUCTION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; ATOPY; CD4+ T LYMPHOCYTE; CELL SURVIVAL; DIARRHEA; DISEASE EXACERBATION; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG SAFETY; DRUG TREATMENT FAILURE; ENZYME INHIBITION; EOSINOPHIL; GENERAL CONDITION DETERIORATION; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; LUNG FUNCTION; MAST CELL; MULTIPLE CYCLE TREATMENT; NAUSEA; NOCTURNAL ASTHMA; NONHUMAN; ORCHIECTOMY; PATHOGENESIS; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT INFLAMMATION; SEX DIFFERENCE; T LYMPHOCYTE; TESTOSTERONE BLOOD LEVEL; TREATMENT PLANNING; TREATMENT RESPONSE;

ADOLESCENT; ADULT; ANDROGENS; ASTHMA; FEMALE; HUMANS; IMMUNOMODULATION; IMMUNOSUPPRESSIVE AGENTS; MALE; SEX FACTORS; TESTOSTERONE;

EID: 79952313416     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.01.006     Document Type: Article

References (37)

1. Osman M. Therapeutic implications of sex differences in asthma and atopy. Arch Dis Child 2003, 88:587-590.
2. Bateman E.D., Hurd S.S., Barnes P.J., et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008, 31:143-178.
3. Zannolli R., Morgese G. Does puberty interfere with asthma?. Med Hypotheses 1997, 48:27-32.
4. Ninan T.K., Russell G. Respiratory symptoms and atopy in Aberdeen schoolchildren: evidence from two surveys 25 years apart. BMJ 1992, 304:873-875.
5. Mulligan T., Frick M.F., Zuraw Q.C., Stemhagen A., MC Whirter C. Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int J Clin Pract 2006, 60:762-769.
6. Fauci A., Braunwald E., Kasper D. Harrison's principles of internal medicine 2008, McGraw Hill, New York. 17th ed.
7. Barbee R.A., Halonen M., Kaltenborn W., Lebowitz M., Burrows B. A longitudinal study of serum IgE in a community cohort: correlations with age, sex, smoking, and atopic status. J Allergy Clin Immunol 1987, 79:919-927.
8. Yamatomo T., Okano M., Ono T., et al. Sex-related differences in the initiation of allergic rhinitis in mice. Allergy 2001, 56:525-531.
9. Sudo N., Yu X.N., Kubo C. Dehydroepiandrosterone attenuates the spontaneous elevation of serum IgE level in NC/Nga mice. Immunol Lett 2001, 79:177-179.
10. Yu C.K., Yang B.C., Lei H.Y., et al. Attenuation of house dust mite Dermatophagoides farinae-induced airway allergic responses in mice by dehydroepiandrosterone is correlated with down-regulation of TH2 response. Clin Exp Allergy 1999, 29:414-422.
11. Shaheen S.O., Hines M., Newson R.B., et al. Maternal testosterone in pregnancy and atopic outcomes in childhood. Allergy 2007, 62:25-32.
12. Araneo B.A., Dowell T., Diegel M., Daynes R.A. Dihydrotestosterone exerts a depressive influence on the production of interleukin-4 (IL-4), IL-5, and gamma-interferon, but not IL-2 by activated murine T cells. Blood 1991, 78:688-699.
13. Liva S.M., Voskuhl R.R. Testosterone acts directly on CD4+ T lymphocytes to increase IL-10 production. J Immunol 2001, 167:2060-2067.
14. Malkin C.J., Pugh P.J., Jones R.D., Kapoor D., Channer K.S., Jones T.H. The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men. J Clin Endocrinol Metab 2004, 89:3313-3318.
15. Page S.T., Plymate S.R., Bremner W.J., et al. Effect of medical castration on CD4+ CD25+ T cells, CD8+ T cell IFN-gamma expression, and NK cells: a physiological role for testosterone and/or its metabolites. Am J Physiol Endocrinol Metab 2006, 290:E856-E863.
16. Corrales J.J., Almeida M., Burgo R., Mories M.T., Miralles J.M., Orfao A. Androgen-replacement therapy depresses the ex vivo production of inflammatory cytokines by circulating antigen-presenting cells in aging type-2 diabetic men with partial androgen deficiency. J Endocrinol 2006, 189:595-604.
17. Nettleship J.E., Pugh P.J., Channer K.S., Jones T., Jones R.D. Inverse relationship between serum levels of interleukin-1beta and testosterone in men with stable coronary artery disease. Horm Metab Res 2007, 39:366-371.
18. Grahn B., Henningsson S.S., Kahlson G., Rosengren E. Alterations in the activities of ornithine and histidine decarboxylases provoked by testosterone in mice. Br J Pharmacol 1973, 48:113-120.
19. Martin S.A., Taylor B.A., Watanabe T., Bulfield G. Histidine decarboxylase phenotypes of inbred mouse strains: a regulatory locus (Hdc) determines kidney enzyme concentration. Biochem Genet 1984, 22:305-322.
20. Wilson C.M., McPhaul M.J. A and B forms of the androgen receptor are expressed in a variety of human tissues. Mol Cell Endocrinol 1996, 120:51-57.
21. Davis S.R., McCloud P., Strauss B.J., Burger H. Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality. Maturitas 1995, 21:227-236.
22. Floter A., Nathorst-Boos J., Carlstrom K., von Schoultz B. Addition of testosterone to estrogen replacement therapy in oophorectomized women: effects on sexuality and well-being. Climacteric 2002, 5:357-365.
23. Nieschlag E., Behr H. Testosterone. Action, deficiency, substitution 2004, Cambridge University Press, Cambridge. 1st ed.
24. Collins S., Quarmby V.E., French F.S., Lefkowitz R.J., Caron M.G. Regulation of the beta 2-adrenergic receptor and its mRNA in the rat ventral prostate by testosterone. FEBS Lett 1988, 233:173-176.
25. Boswell-Smith V., Spina D., Page C.P. Phosphodiesterase inhibitors. Br J Pharmacol 2006, 147(Suppl 1):S252-S257.
26. Spina D. PDE4 inhibitors: current status. Br J Pharmacol 2008, 155:308-315.
27. Svartberg J., Schirmer H., Medbo A., Melbye H., Aasebo U. Reduced pulmonary function is associated with lower levels of endogenous total and free testosterone. The Tromso Study. Eur J Epidemiol 2007, 22:107-112.
28. Shabsigh R., Kaufman J.M., Steidle C., Padma-Nathan H. Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone. J Urol 2008, 179:S97-S102.
29. Traish A.M., Park K., Dhir V., Kim N.N., Moreland R.B., Goldstein I. Effects of castration and androgen replacement on erectile function in a rabbit model. Endocrinology 1999, 140:1861-1868.
30. Aversa A., Isidori A.M., De Martino M.U., et al. Androgens and penile erection: evidence for a direct relationship between free testosterone and cavernous vasodilation in men with erectile dysfunction. Clin Endocrinol (Oxf) 2000, 53:517-522.
31. Traish A.M., Saad F., Feeley R.J., Guay A. The dark side of testosterone deficiency: III cardiovascular disease. J Androl 2009, 30:477-494.
32. Kouloumenta V., Hatziefthimiou A., Paraskeva E., Gourgoulianis K., Molyvdas P.A. Non-genomic effect of testosterone on airway smooth muscle. Br J Pharmacol 2006, 149:1083-1091.
33. Cheuk B.L., Leung P.S., Lo A.C., Wong P.Y. Androgen control of cyclooxygenase expression in the rat epididymis. Biol Reprod 2000, 63:775-780.
34. Sutherland E.R. Nocturnal asthma. J Allergy Clin Immunol 2005, 116:1179-1186.
35. Brambilla D.J., Matsumoto A.M., Araujo A.B., McKinlay J.B. The effect of diurnal variation on clinical measurement of serum testosterone and other sex hormone levels in men. J Clin Endocrinol Metab 2009, 94:907-913.
36. Wulfsohn N.L., Politzer W.M., Henrico J.S. Testosterone therapy in bronchial asthma. S Afr Med J 1964, 38:170-172.
37. Mileva Z., Maleeva A. The serum testosterone level of patients with bronchial asthma treated with corticosteroids and untreated. Vutr Boles 1988, 27:29-32.